The Infection Control Today® prevention page contains news and information on the latest updates on all facets of infection prevention. From vaccinations and immunizations to controlling air and water flow in a health care system, preventing infections falls not only on the infection prevention staff, but on all who interact within the hospital, from environmental services teams to those planning and building new construction.
November 29th 2024
The Bug of the Month helps educate readers about existing and emerging pathogens that are clinically important in today's health care facilities.
How to Address Concerns About the Influenza Vaccine
December 2nd 2022Reluctance to receive the influenza vaccine continues despite years-long campaigns to increase vaccination rates. William Schaffner, MD, speaks to ICT® about how health care workers can respond to the most common questions and assure of the vaccine’s safety and efficacy.
LTC Facilities Face Unique Infection Control Issues During COVID-19 Pandemic
November 29th 2022Integrating home and community, long-term care facilities are supposed to be a haven for patients and their families. But during the COVID-19 pandemic, keeping the patients and the staff safe was a constant battle. An infection preventionist who lived through it discusses the challenges at her facility.
Selling Programs to Your C-Suite: 5 Key Steps to Success
November 22nd 2022When an infection preventionist, environmental hygienist, or any other health care worker sees the need and value of a technology, product, or program, but purchasing it isn’t in the department or facility’s funds, how do you convince the C-suite to buy it anyway?
Reducing C difficile Transmission by Drafting the ED and EMS
November 16th 2022Most often, the first place a patient enters a hospital is through the emergency department and sometimes by emergency medical services. Where else to better stop Clostridioides difficile from coming into the hospital than at the entrance?
Potential Core Inhibitors in Hepatitis B Virus Presented at the AASLD, The Liver Meeting
November 15th 2022While treatments are available for hepatitis B virus, no long-term cure has been developed. Progress so far indicates that this core inhibitor candidate is potentially ready for clinical studies.
Developing Vaccines to Fight Sepsis Caused by ExPEC and S. aureus
November 11th 2022Extra-intestinal pathogenic Escherichia coli (ExPEC) and Staphylococcus aureus (S. aureus) are 2 of the leading causes of severe sepsis, and Janssen Pharmaceutical Companies of Johnson & Johnson is developing vaccines to fight those diseases.